Emcure Pharmaceuticals Limited has submitted a regulatory filing to the National Stock Exchange of India Limited and BSE Limited intimating its proposed schedule of participation in an investor meeting. This disclosure is made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
The company has provided the following schedule:
- Day & Date: Monday, November 16, 2026
- Event: JM Financial Annual India Conference - India Xchange 2026
- City: Mumbai
- Mode: Physical
The company explicitly states that the schedule is tentative and may change due to exigencies on the part of investors or the company. Importantly, the disclosure confirms that no unpublished price sensitive information is proposed to be shared or discussed with analysts or investors during this meeting.
The document is signed by Amruta Yangalwar, Company Secretary & Compliance Officer (ICSI Membership Number: A25687), and includes the company's registered office details: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India.